These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 7508113)
21. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival. Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223 [TBL] [Abstract][Full Text] [Related]
22. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [TBL] [Abstract][Full Text] [Related]
23. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381 [TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical detection of proliferative cells. Mokrý J; Nĕmecek S Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(3):107-13. PubMed ID: 8685626 [TBL] [Abstract][Full Text] [Related]
25. Clinicopathological study of choroid plexus tumors: immunohistochemical features and evaluation of proliferative potential by PCNA and Ki-67 immunostaining. Kato T; Fujita M; Sawamura Y; Tada M; Abe H; Nagashima K; Nakamura N Noshuyo Byori; 1996 Nov; 13(2):99-105. PubMed ID: 8958514 [TBL] [Abstract][Full Text] [Related]
26. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors. Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650 [TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma. Tamboli P; Amin MB; Schultz DS; Linden MD; Kubus J Mod Pathol; 1996 Oct; 9(10):1015-9. PubMed ID: 8902840 [TBL] [Abstract][Full Text] [Related]
28. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of Ki-67 labeling index in urothelial tumors of the renal pelvis and ureter. Masuda M; Iki M; Takano Y; Asakura T; Noguchi S; Ikeda I; Kubota Y; Hosaka M J Urol; 1996 Jun; 155(6):1877-80; discussion 1880-1. PubMed ID: 8618278 [TBL] [Abstract][Full Text] [Related]
30. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002). Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784 [TBL] [Abstract][Full Text] [Related]
31. Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunocytochemical study using supersensitive monoclonal antibodies and the biotin-streptavidin-amplified method. Alexiev BA Diagn Cytopathol; 1996 Nov; 15(4):277-81. PubMed ID: 8982580 [TBL] [Abstract][Full Text] [Related]
32. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings. Serio G Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759 [TBL] [Abstract][Full Text] [Related]
33. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Holt PR; Moss SF; Kapetanakis AM; Petrotos A; Wang S Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):131-5. PubMed ID: 9037564 [TBL] [Abstract][Full Text] [Related]
34. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111 [TBL] [Abstract][Full Text] [Related]
35. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices. Oka K; Nakano T; Hoshi T Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096 [TBL] [Abstract][Full Text] [Related]
36. Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior. Brown HM; Komorowski RA; Wilson SD; Demeure MJ; Zhu YR Cancer; 1999 Oct; 86(8):1583-9. PubMed ID: 10526289 [TBL] [Abstract][Full Text] [Related]
37. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics. Swanson SA; Brooks JJ Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714 [TBL] [Abstract][Full Text] [Related]
38. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Dervan PA; Magee HM; Buckley C; Carney DN Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S21-8. PubMed ID: 1349455 [TBL] [Abstract][Full Text] [Related]
39. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry. Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877 [TBL] [Abstract][Full Text] [Related]
40. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. Pich A; Ponti R; Valente G; Chiusa L; Geuna M; Novero D; Palestro G J Clin Pathol; 1994 Jan; 47(1):18-22. PubMed ID: 7907607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]